The American journal of managed care
The most recent articles from:
Am J Manag Care
-
To measure the impact of state Medicaid formulary policies on costs for patients with schizophrenia and bipolar disorder. ⋯ Applying formulary restrictions to atypical antipsychotics is associated with higher total medical expenditures for patients with schizophrenia and bipolar disorder in Medicaid. Combined with the other social costs such as an increase in incarceration rates, these formulary restrictions could increase state costs by $1 billion annually, enough to offset any savings in pharmacy costs.